ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

NKTR Nektar Therapeutics

1,33
0,01 (0,76%)
27 Apr 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Nektar Therapeutics NKTR NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
0,01 0,76% 1,33 02:00:00
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
1,33 1,31 1,38 1,33 1,32
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
22.3.202419:00PRNUSNektar Management to Present at the H.C. Wainwright 2nd..
05.3.202423:11EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
05.3.202415:00PRNUSNektar Therapeutics Announces Initiation of Phase 2b..
04.3.202422:20EDGAR2Form 8-K - Current report
04.3.202422:15PRNUSNektar Therapeutics Reports Fourth Quarter and Year-End 2023..
04.3.202414:40EDGAR2Form 8-K - Current report
04.3.202414:30PRNUSNektar Therapeutics Announces $30 Million Private Placement..
28.2.202400:00PRNUSNektar Management to Present at the TD Cowen 44th Annual..
27.2.202400:00PRNUSNektar to Announce Financial Results for the Fourth Quarter..
23.2.202402:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23.2.202402:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23.2.202402:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20.2.202421:55EDGAR2Form 144 - Report of proposed sale of securities
20.2.202421:51EDGAR2Form 144 - Report of proposed sale of securities
20.2.202421:50EDGAR2Form 144 - Report of proposed sale of securities
16.2.202423:16EDGAR2Form 8-K - Current report
14.2.202423:03EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14.2.202414:50EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
10.1.202422:25EDGAR2Form 8-K - Current report
04.1.202400:00PRNUSNektar Management To Present at the 42nd Annual J.P. Morgan..
16.12.202300:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16.12.202300:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16.12.202300:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15.12.202318:18EDGAR2Form 144 - Report of proposed sale of securities
12.12.202300:00PRNUSNektar and Collaborators Present Preclinical Data on..
27.11.202322:55EDGAR2Form 8-K - Current report
21.11.202303:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21.11.202303:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21.11.202302:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17.11.202322:36EDGAR2Form 144 - Report of proposed sale of securities
17.11.202322:15EDGAR2Form 144 - Report of proposed sale of securities
17.11.202322:10EDGAR2Form 144 - Report of proposed sale of securities
07.11.202322:21EDGAR2Form 8-K - Current report
07.11.202322:15PRNUSNektar Therapeutics Reports Third Quarter 2023 Financial..
31.10.202323:00PRNUSNektar to Announce Financial Results for the Third Quarter..
13.10.202314:30PRNUSNektar Presents New Responder Data for Rezpegaldesleukin, a..
02.10.202315:00PRNUSNektar Therapeutics Announces Two Abstracts Accepted at EADV..
27.9.202315:00PRNUSNektar Therapeutics Announces New Clinical Study..
22.9.202302:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21.9.202302:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21.9.202302:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21.9.202302:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21.9.202302:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21.9.202302:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18.9.202323:06EDGAR2Form 144 - Report of proposed sale of securities
13.9.202315:00PRNUSNektar Therapeutics Announces Promising New Data from Phase..
08.9.202323:16EDGAR2Form 8-K - Current report
07.9.202300:00PRNUSNektar Therapeutics to Host Virtual Investor & Analyst Event..
18.8.202302:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18.8.202302:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Kürzlich von Ihnen besucht

Delayed Upgrade Clock